TGFB1 and neoplasm: It is widely accepted that TGFβ has direct immunosuppressive activity on CD8+ cytotoxic T cells, the critical warheads that eliminate tumor cells through antigen-specific synaptic engagement and injection of cytotoxic enzymes.